Blog
The Official Blog of the University Health Network’s Red Blood Cell Disorders Clinic. Stories that matter.
THE RBCD HUB // BLOG
Top Five Things to do during Transfusion
A Business Developer, Registered Nurse, MBA candidate, and Board Trustee of the Thalassemia Foundation – Shirin is always on the go! We caught up with Shirin and asked about her top five things to do during transfusion.
The RBCD Clinic’s Wholistic Health Series
The University Health Network's Red Blood Cell Disorders Clinic is inviting patients, families, and caregivers impacted by Sickle Cell Disease, Thalassemia, and other Red Blood Disorders to join us for a FREE Five-Part Wholistic Health Series.
Ontario Health Launches the Quality Standard for Sickle Cell Disease!
On January 26, 2023, Ontario Health launched new health standards to improve care for people living with Sickle Cell Disease (SCD), setting the stage for high quality care.
Down with Capitalism! How to take Better Care of Yourself while living with Sickle Cell Disease
From the time we are born, we are asked as children, ‘what do you want to be when you grow up?’ Then, from childhood to adulthood, you change your mind, probably…
Why a Primary Care Provider is an Important Part of My Health Care Team
A primary care provider is the person who is most responsible for your overall health care across your life. They can either be a family doctor or a nurse practitioner…
The Role of Patient Relations in RBCD Care at UHN
The Patient Relations Department at the University Health Network helps to support patients and families through their health care experiences by addressing questions, complaints, suggestions, and compliments…
Race, Racism, and Sickle Cell Disease: Where it Began and Where it Ends
A genetic illness, Sickle Cell Disease (SCD) can affect anyone. It is commonly diagnosed in people of African, Hispanic-American, Middle Eastern, Indian, and Mediterranean descent.
Grabbing the Bull by the Horns: Why Human Rights Matter for Sickle Cell Disease
Sickle cell disease (SCD) is famously understood as the world’s first “molecular disease.” However, this medical model ignores the social aspects of SCD, including disability, race, and gender.